Based on the widely established concept that COX, LOX, and the CYP-EET/sEH axis play important roles in cardiovascular disease as well as in tumor growth and metastasis, the development of drugs or biological products that target COX, LOX, CYP enzymes, or the sEH has bright prospects. Here, EPHX2 is linked to cardiovascular disorder.